Check out the post on LinkedIn.
its compelling and they are now drawing out the point of difference nicely.
https://www.linkedin.com/posts/nextscience_xbio-in-action-p-aeruginosa-activity-7153037506416943106-0qH3?utm_source=share&utm_medium=member_ios
Ann: XPERIENCE study findings published, page-17
Add NXS (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
20.0¢ |
Change
-0.010(4.76%) |
Mkt cap ! $58.43M | |||
| Open | High | Low | Value | Volume |
| 20.0¢ | 20.0¢ | 20.0¢ | $8.901K | 44.50K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 2 | 20000 | 19.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 20.0¢ | 16060 | 1 |
View Market Depth
| Last trade - 10.51am 08/10/2024 (20 minute delay) ? |
| NXS (ASX) Chart |